# Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

> **NCT00004286** · PHASE3 · COMPLETED · sponsor: **National Center for Research Resources (NCRR)** · enrollment: 120 (—)

## Conditions studied

- Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

## Interventions

- **DRUG:** immune globulin

## Key facts

- **NCT ID:** NCT00004286
- **Lead sponsor:** National Center for Research Resources (NCRR)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-02
- **Primary completion:** —
- **Final completion:** 1999-11
- **Target enrollment:** 120 (—)
- **Last updated:** 2005-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004286, "Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*